Cargando…

A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines

BACKGROUND: The potency of inactivated influenza vaccines is determined using a single radial immunodiffusion (SRID) assay. This assay is relatively easy to standardize, it is not technically demanding, and it is capable of measuring the potency of several vaccine strain subtypes in a multivalent va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmeisser, Falko, Vasudevan, Anupama, Soto, Jackeline, Kumar, Arunima, Williams, Ollie, Weir, Jerry P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181825/ https://www.ncbi.nlm.nih.gov/pubmed/25087462 http://dx.doi.org/10.1111/irv.12272

Ejemplares similares

Potency determination of inactivated H7 influenza vaccines using monoclonal antibody‐based ELISA and biolayer interferometry assays
por: Vasudevan, Anupama, et al.
Publicado: (2017)

Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies
por: Verma, Swati, et al.
Publicado: (2017)

Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin
por: Schmeisser, Falko, et al.
Publicado: (2012)

A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines
por: Schmeisser, Falko, et al.
Publicado: (2016)

Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.4
por: Schuele, Carlotta, et al.
Publicado: (2023)

Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge
por: Schmeisser, Falko, et al.
Publicado: (2015)

Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it
por: Wang, Wei, et al.
Publicado: (2019)

Confronting the next pandemic—Workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27–29, 2010
por: Hardy, Stephanie, et al.
Publicado: (2011)

Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies
por: Alvarado-Facundo, Esmeralda, et al.
Publicado: (2016)

Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes
por: Schmeisser, Falko, et al.
Publicado: (2007)

Determination of H5N1 vaccine potency using reference antisera from heterologous strains of influenza
por: Vodeiko, Galina M., et al.
Publicado: (2011)

Monoclonal IgA Antibodies for Aflatoxin Immunoassays
por: Ertekin, Özlem, et al.
Publicado: (2016)

Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency
por: Cai, Cindy X., et al.
Publicado: (2022)

Preparation of Monoclonal Antibody against Deoxynivalenol and Development of Immunoassays
por: Mokhtar, Hoyda Elsir, et al.
Publicado: (2022)

Rapid determination of influenza vaccine potency by an SPR-based method using subtype or lineage-specific monoclonal antibodies
por: Narayan, Kartik, et al.
Publicado: (2023)

Monoclonal antibodies specific for Bacteroides fragilis enterotoxins BFT1 and BFT2 and their use in immunoassays
por: Mootien, Saraspadee, et al.
Publicado: (2017)

AFIR: A Dimensionless Potency Metric for Characterizing the Activity of Monoclonal Antibodies
por: Stein, AM, et al.
Publicado: (2017)

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines
por: Meseda, Clement A., et al.
Publicado: (2016)

DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome()
por: Meseda, Clement A., et al.
Publicado: (2004)

A general process for the development of peptide-based immunoassays for monoclonal antibodies
por: Sanchez, Ana B., et al.
Publicado: (2010)

Preparation of an Antidanofloxacin Monoclonal Antibody and Development of Immunoassays for Detecting Danofloxacin in Meat
por: Yuan, Meifang, et al.
Publicado: (2020)

Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies
por: Chae, Wonil, et al.
Publicado: (2019)

Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors()
por: Saxena, Latika, et al.
Publicado: (2015)

Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase
por: Meseda, Clement A., et al.
Publicado: (2018)

Development of Immunoassay Based on Monoclonal Antibody Reacted with the Neonicotinoid Insecticides Clothianidin and Dinotefuran
por: Uchigashima, Mikiko, et al.
Publicado: (2012)

Monoclonal Antibodies and Immunoassay for Medical Plant-Derived Natural Products: A Review
por: Yan, Xin, et al.
Publicado: (2017)

Monoclonal Antibody-Based Colorimetric Lateral Flow Immunoassay for the Detection of Pyridaben in the Environment
por: Chen, He, et al.
Publicado: (2023)

Establishment of an Enzyme Immunoassay Using Monoclonal Antibody (HG1‐219) and Its Application for the Diagnosis of Hepatocellular Carcinoma
por: Hada, Toshikazu, et al.
Publicado: (1992)

H1N1 influenza virus epitopes classified by monoclonal antibodies
por: Guo, Chunyan, et al.
Publicado: (2018)

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617
por: Peng, Lei, et al.
Publicado: (2021)

Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617
por: Peng, Lei, et al.
Publicado: (2022)

Emerging Antigenic Variants at the Antigenic Site Sb in Pandemic A(H1N1)2009 Influenza Virus in Japan Detected by a Human Monoclonal Antibody
por: Yasugi, Mayo, et al.
Publicado: (2013)

Comparison of Pandemic (H1N1) 2009 and Seasonal Influenza, Western Australia, 2009
por: Carcione, Dale, et al.
Publicado: (2010)

Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient
por: Hu, Weibin, et al.
Publicado: (2013)

Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors: Fc-mediated avidity enhances the potency of an anti-TLR4 antibody
por: Loyau, Jérémy, et al.
Publicado: (2014)

Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
por: Agadjanyan, Michael G., et al.
Publicado: (2017)

Highly pathogenic avian influenza A/Guangdong/17SF003/2016 is immunogenic and induces cross-protection against antigenically divergent H7N9 viruses
por: Radvak, Peter, et al.
Publicado: (2021)

An Ultra-Sensitive Monoclonal Antibody-Based Competitive Enzyme Immunoassay for Sterigmatocystin in Cereal and Oil Products
por: Li, Min, et al.
Publicado: (2014)

Development of Monoclonal Antibodies and Immunoassays for Sensitive and Specific Detection of Shiga Toxin Stx2f
por: Skinner, Craig, et al.
Publicado: (2013)

QSAR analysis of immune recognition for triazine herbicides based on immunoassay data for polyclonal and monoclonal antibodies
por: Buglak, Andrey A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m1fuhu0bn8i4mhrnovv3p42la6